SDS

Date Printed: 6/27/2019
9. Physical and Chemical Properties
Appearance:
Aerosolized Mist
Physical State:
Liquid
Odor:
Solvent Like
Odor Threshold:
N.E.
Specific Gravity:
0.902
pH:
N.A.
Freeze Point, °C:
ND
Viscosity:
NE
Solubility in Water:
Slight
Partition Coefficient, n-octanol/
water:
N.D.
Decompostion Temp., °C:
N.D.
Boiling Range, °C:
-44 - 537
Explosive Limits, vol%:
0.9 - 13.0
Flammability:
Supports Combustion
Flash Point, °C:
-104
Evaporation Rate:
Faster than Ether
Auto-ignition Temp., °C:
N.D.
Vapor Density:
Heavier than Air
Vapor Pressure:
N.D.
(See "Other information" Section for abbreviation legend)
10. Stability and Reactivity
CONDITIONS TO AVOID: Avoid temperatures above 120°F (49°C). Avoid all possible sources of ignition.
INCOMPATIBILITY: Incompatible with strong oxidizing agents, strong acids and strong alkalies.
HAZARDOUS DECOMPOSITION: By open flame, carbon monoxide and carbon dioxide. When heated to decomposition, it emits
acrid smoke and irritating fumes. Contains solvents which may form carbon monoxide, carbon dioxide, and formaldehyde.
HAZARDOUS POLYMERIZATION: Will not occur under normal conditions.
STABILITY: This product is stable under normal storage conditions.
11. Toxicological Information
EFFECTS OF OVEREXPOSURE - EYE CONTACT: Causes Serious Eye Irritation
EFFECTS OF OVEREXPOSURE - SKIN CONTACT: Substance may cause slight skin irritation. May cause skin irritation. Allergic
reactions are possible. Prolonged or repeated contact may cause skin irritation.
EFFECTS OF OVEREXPOSURE - INHALATION: Harmful if inhaled. High gas, vapor, mist or dust concentrations may be harmful if
inhaled. Avoid breathing fumes, spray, vapors, or mist. High vapor concentrations are irritating to the eyes, nose, throat and lungs.
Prolonged or excessive inhalation may cause respiratory tract irritation.
EFFECTS OF OVEREXPOSURE - INGESTION: Harmful if swallowed.
EFFECTS OF OVEREXPOSURE - CHRONIC HAZARDS: May cause central nervous system disorder (e.g., narcosis involving a
loss of coordination, weakness, fatigue, mental confusion, and blurred vision) and/or damage. High concentrations may lead to
central nervous system effects (drowsiness, dizziness, nausea, headaches, paralysis, and blurred vision) and/or damage. Reports
have associated repeated and prolonged occupational overexposure to solvents with permanent brain and nervous system damage.
Overexposure to xylene in laboratory animals has been associated with liver abnormalities, kidney, lung, spleen, eye and blood
damage as well as reproductive disorders. Effects in humans, due to chronic overexposure, have included liver, cardiac
abnormalities and nervous system damage. IARC lists Ethylbenzene as a possible human carcinogen (group 2B). Contains Titanium
Dioxide. Titanium Dioxide is listed as a Group 2B-"Possibly carcinogenic to humans" by IARC. No significant exposure to Titanium
Dioxide is thought to occur during the use of products in which Titanium Dioxide is bound to other materials, such as in paints during
brush application or drying. Risk of overexposure depends on duration and level of exposure to dust from repeated sanding of
surfaces or spray mist and the actual concentration of Titanium Dioxide in the formula. (Ref: IARC Monograph, Vol. 93, 2010)
PRIMARY ROUTE(S) OF ENTRY: Eye Contact, Ingestion, Inhalation, Skin Absorption, Skin Contact
ACUTE TOXICITY VALUES
The acute effects of this product have not been tested. Data on individual components are tabulated below:
CAS-No.
Chemical Name Oral LD50 Dermal LD50 Vapor LC50
67-64-1 Acetone 5800 mg/kg Rat >15700 mg/kg Rabbit 50.1 mg/L Rat
64742-49-0 Naphtha, Petroleum, Hydrotreated Light >5000 mg/kg Rat >3160 mg/kg Rabbit >4951 mg/L Rat
123-86-4 n-Butyl Acetate 10768 mg/kg Rat >17600 mg/kg Rabbit > 21 mg/L Rat
13463-67-7 Titanium Dioxide >10000 mg/kg Rat 2500 mg/kg N.E.
106-97-8 n-Butane N.E. N.E. 658 mg/L Rat
1330-20-7 Xylenes (o-, m-, p- isomers) 3500 mg/kg Rat >4350 mg/kg Rabbit 29.08 mg/L Rat
100-41-4 Ethylbenzene 3500 mg/kg Rat 15400 mg/kg Rabbit 17.4 mg/L Rat
111-65-9 Octane N.E. N.E. >23.36 mg/L Rat
N.E. - Not Established
Page 4 / 6